Literature DB >> 19124737

A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells.

Emily M Mace1, Susan J Monkley, David R Critchley, Fumio Takei.   

Abstract

LFA-1 is critical for NK cell cytotoxicity because it mediates adhesion of NK cells to target cells. Talin is thought to associate with the cytoplasmic tail of LFA-1 and activates its ligand-binding function. In this study, we report that talin is also required for LFA-1-mediated outside-in signaling leading to NK cell polarization. NK cells generated from talin1-deficient murine embryonic stem cells are defective in LFA-1-mediated adhesion. Although exogenously added manganese activates LFA-1 on talin-deficient NK cells and induces conjugate formation with target cells, their LFA-1-dependent cytotoxicity is impaired. Binding of ICAM-1-coated beads to wild-type NK cells induces reorganization of the actin cytoskeleton and coligation of the activating receptor NKG2D induces polarization of cytotoxic granules, whereas talin1-deficient NK cells fail to polarize with or without NKG2D coligation. Thus, talin1 plays a dual role in NK cell cytotoxicity, first by activation of LFA-1-mediated adhesion and then via LFA-1-induced NK cell polarization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124737     DOI: 10.4049/jimmunol.182.2.948

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells.

Authors:  Michael E March; Eric O Long
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.

Authors:  Katelynn M Wilton; Brittany L Overlee; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2019-07-18       Impact factor: 5.285

Review 3.  Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2009-07-17       Impact factor: 53.106

4.  Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization.

Authors:  Catharina C Gross; Joseph A Brzostowski; Dongfang Liu; Eric O Long
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

Review 5.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 6.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

7.  Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity.

Authors:  Hyoungjun Ham; Sabrice Guerrier; JungJin Kim; Renee A Schoon; Erik L Anderson; Michael J Hamann; Zhenkun Lou; Daniel D Billadeau
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

8.  VASP Regulates NK Cell Lytic Granule Convergence.

Authors:  Katelynn M Wilton; Daniel D Billadeau
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

9.  Secretory TRAIL-Armed Natural Killer Cell-Based Therapy: In Vitro and In Vivo Colorectal Peritoneal Carcinomatosis Xenograft.

Authors:  Xinxin Song; Se-Hoon Hong; William T Kwon; Lisa M Bailey; Per Basse; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Mol Cancer Ther       Date:  2016-04-12       Impact factor: 6.261

10.  Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes.

Authors:  Aradhana Awasthi; Asanga Samarakoon; Haiyan Chu; Rajasekaran Kamalakannan; Lawrence A Quilliam; Magdalena Chrzanowska-Wodnicka; Gilbert C White; Subramaniam Malarkannan
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.